Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations

Quadrupling inhaled glucocorticoid dose to abort asthma exacerbations

Asthma exacerbations are frightening for patients and are occasionally fatal. We tested the concept that a plan for patients to manage their asthma (self-management plan), which included a temporary quadrupling of the dose of inhaled glucocorticoids when asthma control started to deteriorate, would...

書目詳細資料
Main Authors:	McKeever, T, Mortimer, K, Wilson, A, Walker, S, Brightling, C, Skeggs, A, Pavord, I, Price, D, Duley, L, Thomas, M, Bradshaw, L, Higgins, B, Haydock, R, Mitchell, E, Devereux, G, Harrison, T
格式:	Journal article
語言:	English
出版:	Massachusetts Medical Society 2018

相似書籍

Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST
由: McKeever, T, et al.
出版: (2018)

FourFold Asthma Study (FAST): a study protocol for a randomised controlled trial evaluating the clinical cost-effectiveness of temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations.
由: Skeggs, A, et al.
出版: (2016)

Inhaled glucocorticoids and COPD exacerbations.
由: Brightling, C, et al.
出版: (2015)

Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial
由: Mckeever, T, et al.
出版: (2017)

Peak expiratory flow sequence in acute exacerbations of asthma.
由: Birring, S, et al.
出版: (2001)

Exacerbations of severe asthma in patients treated with mepolizumab
由: Shrimanker, R, et al.
出版: (2018)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
由: Haldar, P, et al.
出版: (2009)

Glucocorticoids and mepolizumab in eosinophilic asthma.
由: Bel, E, et al.
出版: (2014)

Bone loss and inhaled glucocorticoids.
由: van Staa, T, et al.
出版: (2002)

Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study.
由: Wilson, E, et al.
出版: (2014)

Treating asthma exacerbations in athletes: TUE or not TUE?
由: Hull, J, et al.
出版: (2017)

Pharmacokinetic optimisation of inhaled steroid therapy in asthma.
由: Pavord, I, et al.
出版: (1993)

Reply to: inhaled corticosteroids and adult asthma
由: Beasley, R, et al.
出版: (2019)

Asthma progression and mortality: The role of inhaled corticosteroids
由: O'Byrne, P, et al.
出版: (2019)

Association between blood eosinophil count and exacerbation risk in patients with asthma receiving medium- or high-dosage inhaled corticosteroids
由: Kerkhof, M, et al.
出版: (2017)

Inhaled corticosteroids in COPD.
由: Brightling, C, et al.
出版: (1999)

EAACI position statement on asthma exacerbations and severe asthma.
由: Custovic, A, et al.
出版: (2013)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
由: Shrimanker, R, et al.
出版: (2017)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
由: Green, R, et al.
出版: (2002)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
由: Siddiqui, S, et al.
出版: (2018)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
由: Berry, M, et al.
出版: (2007)

Refractoriness to inhaled sodium metabisulphite in subjects with mild asthma.
由: Pavord, I, et al.
出版: (1994)

The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
由: Russell, R, et al.
出版: (2019)

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
由: Green, R, et al.
出版: (2006)

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations
由: Rastogi, S, et al.
出版: (2017)

Effect of inhaled prostaglandin E2 on allergen-induced asthma.
由: Pavord, I, et al.
出版: (1993)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
由: Bel, E, et al.
出版: (2014)

Improved muscular weakness during asthma exacerbation
由: Delstanche, S, et al.
出版: (2017)

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids.
由: Green, R, et al.
出版: (2002)

Asthma exacerbations and sputum eosinophil counts.
由: Currie, G, et al.
出版: (2003)

Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles
由: Ghebre, M, et al.
出版: (2018)

Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids.
由: Pavord, I, et al.
出版: (1992)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
由: Howell, I, et al.
出版: (2024)

Effect of 443c81, an inhaled mu-opioid receptor agonist in asthma.
由: Pavord, I, et al.
出版: (1994)

The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma.
由: Pavord, I, et al.
出版: (1996)

Single inhaler maintenance and reliever therapy (SMART) in general practice asthma management: where are we?
由: Thomas, M, et al.
出版: (2012)

Eosinophils in asthma and airway hyperresponsiveness.
由: Brightling, C, et al.
出版: (2004)

Cough and asthma.
由: Berry, M, et al.
出版: (2003)

COPD: an inhaled corticosteroid-resistant, oral corticosteroid-responsive condition.
由: Saha, S, et al.
出版: (2006)

Inhaled corticosteroid therapy in adult asthma: Time for a new therapeutic dose terminology
由: Beasley, R, et al.
出版: (2019)